Description
Cancer is the second-leading cause of death in the United States. In addition, cancer is one of the most frequently diagnosed serious illnesses, with an estimated 16.9 million Americans with a history of an invasive malignancy alive as of January 1, 2019. Nearly 2 million invasive cancer cases were expected to be diagnosed in 2020. At the beginning of the COVID-19 pandemic, Advocate Aurora Health, Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, the University of Miami, and Vanderbilt University Medical Center (VUMC) led the formation of the COVID-19 and Cancer Consortium (CCC19), to rapidly collect and disseminate information about the especially vulnerable population of patients with active cancer and cancer survivors who are diagnosed with COVID-19. CCC19 started accruing data on March 17, 2020. As of September 2022, 123 institutions across North America have joined the consortium, with more than 15,000 cases reported to date. CCC19 maintains a registry to collect granular data about baseline characteristics, initial course of COVID-19, and longer-term outcomes.
